Breakthroughs changing more than 1.3 billion lives
In 2022, we applied the lightspeed principles that drove the development of our COVID–19 vaccine and treatment to help address unmet needs across all therapeutic areas. Our people continued to live our values—courage, excellence, equity, and joy—pursuing their passions and impacting an evolving world.
Breakthroughs at lightspeed
Pfizer can reach more patients with life-saving treatments, sooner.
Partnerships that Change Patients’ Lives
Pfizer's innovation goals can only be achieved by being the partner of choice for academia, biotechs, advocates, and technological revolutionaries. Some of our partners:
In 2014, Pfizer and OPKO entered into a worldwide agreement for the development and commercialization of NGENLA® for the treatment of growth hormone deficiency.
U.S. Government (PAXLOVID®)
We inked an agreement with the U.S. government to deliver 20 million PAXLOVID courses (nirmatrelvir tablets and ritonavir tablets).
Our work with Tigerlily aims to empower Black women with breast cancer to feel more educated and supported to participate in clinical trials.
These passionate Pfizer colleagues transformed personal visions into large-scale realities that are positively impacting people all over the world.
“Pfizer’s support during this time makes me even prouder of my company. The millions of product donations arranged and the $30 million committed for humanitarian support 1 has and will continue to, quite literally, save lives.”
Ukraine Country Manager
“The Pfizer Refugee Leadership Initiative is not a hand-out. We see what refugees can bring to the table, and we welcome their diverse perspectives and experience.”
Director of Diversity, Equity and Inclusion and Pfizer Refugee Leadership Initiative Founder
“Women are the Chief Health Officers of their families. At Essence Fest, we listened to their stories and we learned. And we will continue to do so in order to better serve them.”
U.S. Covid-19 Vaccine Consumer Experience Lead
- Donations and humanitarian support were arranged by the Pfizer Foundation, a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.